COMMUNIQUÉS West-GlobeNewswire

ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange
02/09/2026
TYLER, Texas, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today [...]
MannKind to Present at Upcoming Investor Conferences
02/09/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , today announced that members of the MannKind management team will present at the following upcoming [...]
SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer
02/09/2026
- Three posters to highlight preclinical activity of SLS009 (tambiciclib) across patient-derived KRAS mutant organoid models of pancreatic cancer – - Studies conducted in collaboration with the University of Wisconsin [...]
Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker
02/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for [...]
AiM Medical Robotics Awarded $2 Million National Cancer Institute Grant to Advance MRI-Guided Robotic Treatment of Brain Cancer
02/09/2026
$2.1M NIH SBIR Phase II grant supports development of AiM’s MRI-compatible neurosurgical robotic platform for precision delivery of ablative brain cancer therapies WORCESTER, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- [...]
AIM ImmunoTech Significantly Expands Ampligen® Global Patent Estate with Long COVID Protection Across Europe and the United Kingdom Through 2041
02/09/2026
Patent protections establish long-duration intellectual property coverage for Ampligen across major European markets and the United Kingdom Latest milestone further strengthens AIM’s expanding global Ampligen patent [...]
HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment
02/09/2026
HCW9302 is a best-in-class IL-2-based immunotherapeutic for treatment of autoimmune diseases through expanding and activating regulatory T cells Patent allowance received for use of HCW9302 as treatment for alopecia [...]
Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds
02/09/2026
RAMAT GAN, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a clinical-stage biotechnology company developing a pipeline of proprietary [...]
Life Line Screening Offers Blood Test That May Provide Early Insight Into Alzheimer’s Disease Risk
02/09/2026
A simple blood test that measures an Alzheimer’s-related biomarker may help adults 55 and older decide whether further evaluation is appropriate, even before symptoms appear INDEPENDENCE, Ohio, Sept. 02, 2026 (GLOBE [...]
The Cost of Loneliness Project Announces a Journey Across America Leading to the First National Day of Connection on Nov. 12
02/09/2026
Founder Lucy Rose begins Walk With Me, a two-month journey through more than 45 communities in 17 states, calling on every American to join a new national tradition: Take 12 at 12 on Nov. 12 WINSTON-SALEM, N.C., Sept. [...]
Levicept Announces Attendance at Cantor and Jefferies Global Healthcare Conferences
02/09/2026
SANDWICH, United Kingdom, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class clinical-stage treatment for osteoarthritis (OA), today [...]
NewBiologix and Synastra Biotechnology Partner to Advance Stable rAAV Manufacturing for Duchenne Muscular Dystrophy Gene Therapy
02/09/2026
Collaboration will use NewBiologix’s Xcell™ platform to establish a scalable manufacturing foundation for Synastra’s investigational DMD gene therapy program LAUSANNE, Switzerland, Sept. 02, 2026 (GLOBE NEWSWIRE) -- [...]
DoKegel Launches Personalized Pelvic Floor Training App for Men
02/09/2026
New DoKegel App Turns a Short Quiz Into a Daily Kegel Routine NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- DoKegel has launched a men's wellness app built around personalized Kegel exercises. The app pairs guided pelvic [...]
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
02/09/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 02, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“ CDT ” or the “ Company ”) today announced that, following the recent issuance of shares and the exercise of [...]
Resalis Therapeutics Appoints Diana M. Røpcke as Chief Medical Officer
02/09/2026
Dr. Røpcke joins Resalis with extensive experience in clinical drug development as well as expertise in obesity and cardiometabolic therapy areas Torino, Italy, September 2, 2026 – Resalis Therapeutics , a biotechnology [...]
Wolverine Stack: Kylo Peptides Introduces New BPC-157 and TB-500 Research Combination
02/09/2026
Sheridan, Wyoming, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides has introduced the Wolverine Stack [ https://kylopeptides.com/product/wolverine-stack/ ] to its research catalog, supplying BPC-157 and TB-500 as two [...]
IBA rejoint l’initiative européenne PFAROS pour accélérer le développement de solutions de destruction des PFAS dans les secteurs de la santé et de la pharmacie
02/09/2026
Louvain ‑ la ‑ Neuve, Belgique, le 2 septembre 2026, 7h00 – IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélérateurs de particules, annonce aujourd’hui sa participation à PFAROS, [...]
IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications
02/09/2026
Louvain-la-Neuve, Belgium, 2 September 2026, 7 a.m. – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its participation in PFAROS, a new European research [...]
Nicox annonce l’extension de son horizon de trésorerie
02/09/2026
Communiqué de presse Nicox annonce l’extension de son horizon de trésorerie Position de trésorerie de 8.4 millions d’euros 1 au 31 août 2026 , suffisante pour financer les opérations actuelles au-delà du 1er trimestre [...]

Pages